Skip to main content
NIH funding notice PAR-23-141

Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)

Closed on May 1, 2023.

Posted
April 4, 2023
Close date
May 1, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $250,771 in first-year total cost, median $250,771.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 ICN-T (90)]1

Most frequent institutions

  1. SCHEPENS EYE RESEARCH INSTITUTE1
Competing awards under PAR-23-141 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023VRC Inhibiting p38 to Prevent and Restore Corneal Scarring1R01EY035947-01CIOLINO, JOSEPH B.SCHEPENS EYE RESEARCH INSTITUTE, MA$250,771ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-23-141: Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) | ScienceDex | ConductScience